China Biotech Services Holdings Limited revenue reports
China Biotech Services Holdings Limited financial reports, China Biotech Services Holdings Limited annual revenue in 2024. When does China Biotech Services Holdings Limited report revenue?
China Biotech Services Holdings Limited total revenue, net income and dynamics of changes in Hong Kong dollar today
Net revenue of China Biotech Services Holdings Limited on 31/03/2021 amounted to 154 169 000 $. The dynamics of China Biotech Services Holdings Limited net revenue has changed by 45 407 000 $ over the last period. China Biotech Services Holdings Limited net income is now 1 819 000 $. Graph of the financial report of China Biotech Services Holdings Limited. The value of "net income" China Biotech Services Holdings Limited on the graph is displayed in blue. All information on China Biotech Services Holdings Limited total revenue on this chart is created in the form of yellow bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
154 169 000 $
+987.15 % ↑
1 819 000 $
-
31/12/2020
108 762 000 $
+474.15 % ↑
8 638 000 $
-
30/09/2020
515 725 000 $
+3 544.440 % ↑
61 800 000 $
-
30/06/2020
18 601 000 $
+29.27 % ↑
-18 172 000 $
-
30/09/2019
14 151 000 $
-
-21 935 000 $
-
30/06/2019
14 389 000 $
-
-19 505 000 $
-
31/03/2019
14 181 000 $
-
-14 708 000 $
-
31/12/2018
18 943 000 $
-
-20 091 000 $
-
Show:
to
China Biotech Services Holdings Limited financial report charts
Dates of China Biotech Services Holdings Limited finance reports: 31/12/2018, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The current date of the financial report of China Biotech Services Holdings Limited for today is 31/03/2021. Gross profit China Biotech Services Holdings Limited is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit China Biotech Services Holdings Limited is 75 220 000 $
China Biotech Services Holdings Limited quarterly report dates
Cost of revenue China Biotech Services Holdings Limited is the total cost of producing and distributing of products and services of a company. Cost of revenue China Biotech Services Holdings Limited is 78 949 000 $ Total revenue China Biotech Services Holdings Limited refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue China Biotech Services Holdings Limited is 154 169 000 $ Operating income China Biotech Services Holdings Limited is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income China Biotech Services Holdings Limited is 38 953 000 $
Net income China Biotech Services Holdings Limited is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income China Biotech Services Holdings Limited is 1 819 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
75 220 000 $
66 519 000 $
263 125 000 $
6 441 000 $
5 307 000 $
5 803 000 $
4 579 000 $
8 155 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
78 949 000 $
42 243 000 $
252 600 000 $
12 160 000 $
8 844 000 $
8 586 000 $
9 602 000 $
10 788 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
154 169 000 $
108 762 000 $
515 725 000 $
18 601 000 $
14 151 000 $
14 389 000 $
14 181 000 $
18 943 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
14 151 000 $
14 389 000 $
14 181 000 $
18 943 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
38 953 000 $
17 300 000 $
222 110 000 $
-19 498 000 $
-22 327 000 $
-21 359 000 $
-14 217 000 $
-20 332 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
1 819 000 $
8 638 000 $
61 800 000 $
-18 172 000 $
-21 935 000 $
-19 505 000 $
-14 708 000 $
-20 091 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
-
-
-
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
115 216 000 $
91 462 000 $
293 615 000 $
38 099 000 $
36 478 000 $
35 748 000 $
28 398 000 $
39 275 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
-
446 313 000 $
-
107 743 000 $
-
133 370 000 $
-
217 982 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
-
904 121 000 $
-
435 989 000 $
-
465 930 000 $
-
337 761 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
-
384 539 000 $
-
59 549 000 $
-
72 940 000 $
-
154 479 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
-
31 126 000 $
-
15 837 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
-
87 065 000 $
-
18 846 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
-
18.69 %
-
5.58 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
343 331 000 $
343 331 000 $
253 715 000 $
253 715 000 $
351 002 000 $
351 002 000 $
324 077 000 $
324 077 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-
-
-
-
Last revenue report of China Biotech Services Holdings Limited was 31/03/2021. According to last financial report total revenue in China Biotech Services Holdings Limited was 154 169 000 Hong Kong dollar and changed by +987.15% since last year. Net income in China Biotech Services Holdings Limited was 1 819 000 $ in last quartal, net income changes to 0%.
China Biotech Services Holdings Limited stocks data
